Southwest Airlines Company Stock News

As the plane was taxiing to the gate, a customer left the aircraft through a rear galley door, a Southwest Airlines spokesperson said.

Stratos Wealth Partners LTD. lowered its stake in shares of Southwest Airlines Co. (NYSE:LUV) by 10.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 40,073 shares of the airlines stock after selling 4,663 shares during the quarter. Stratos Wealth Partners LTD.s holdings in []

Private Advisor Group LLC raised its position in shares of Southwest Airlines Co. (NYSE:LUV) by 36.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 51,821 shares of the airlines stock after acquiring an additional 13,847 shares during the quarter. Private Advisor Group []

Ocugen, Inc. (OCGN) with the stream of -8.72% also noticed, India Southwest Airlines Co. (LUV) encountered a rapid change of -2.34% in the last hour of Fridays trading session. Ocugen, The post Beholding Stock: Ocugen, Inc. (NASDAQ:OCGN), Southwest Airlines Co. (NYSE:LUV) appeared first on Stocks Equity .

DALLAS, Dec. 3, 2021 /PRNewswire/ -- Southwest

Shares of Southwest Airlines Co. (NYSE:LUV) have been assigned a consensus rating of Buy from the twenty-one brokerages that are presently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. The average 1 year target price among brokers []

BLB&B Advisors LLC acquired a new position in shares of Southwest Airlines Co. (NYSE:LUV) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 4,403 shares of the airlines stock, valued at approximately $226,000. Several other hedge funds and other institutional investors also recently modified their holdings []

Nisa Investment Advisors LLC increased its stake in Southwest Airlines Co. (NYSE:LUV) by 5.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 139,715 shares of the airlines stock after purchasing an additional 6,700 shares during the period. Nisa Investment Advisors LLCs []

Southwest Airlines (NYSE:LUV) had its target price decreased by stock analysts at MKM Partners from $61.00 to $56.00 in a research note issued to investors on Wednesday, The Fly reports. The brokerage currently has a buy rating on the airlines stock. MKM Partners target price points to a potential upside of 23.51% from the companys []

DALLAS, Dec. 2, 2021 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) is wrapping up its milestone 50th Anniversary year by releasing a one-of-a-kind commemorative history book, "50 Years. One Heart. A History of Southwest in 50 Objects." Starting today, Southwest® fans can purchase

Shares of Southwest Airlines Co. (NYSE:LUV) hit a new 52-week low during mid-day trading on Tuesday after Raymond James lowered their price target on the stock from $62.00 to $60.00. Raymond James currently has an outperform rating on the stock. Southwest Airlines traded as low as $43.71 and last traded at $44.38, with a volume []

A former Southwest Airlines employee is being sentenced to six months in prison after pleading guilty to possessing stolen guns

Southwest Airlines Co (LUV) shares closed today at 1.6% above its 52 week low of $43.72, giving the company a market cap of $26B. The stock is currently down 4.4% year-to-date, down 6.7% over the past 12 months, and down 2.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 0.6%. Trading Activity Trading volume this week was 29.9% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 59.9% The company's stock price performance over the past 12 months lags the peer average by 34.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 69103.5% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

NEW YORK, NY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) continues to prioritize the necessity for clinical validation as a vital step in bringing its products to market. The Vancouver, Canada-based company, which operates as a specialized health and wellness company that licenses and distributes psychedelic and cannabis-infused products, has established a practice of offering proven products with clinical data, user studies, and scientific research to support its claims. Its a practice that gives Love Pharma a distinct market advantage over many of its competitors. And now, Love Pharma is set to broaden that advantage with its recent announcement that the company has signed a Letter of Intent to acquire MicroDoz Therapy, Inc.